Mental health program for mood and anxiety disorders improve patient outcomes: Study

In a recent study, researchers found that treatment at 'First Episode Mood and Anxiety Program' (FEMAP), a mental health program for youth with mood and anxiety disorders, led to improved patient outcomes.

The study was published in the Journal of Early Intervention in Psychiatry

FEMAP provides treatment to emerging adults, ages 16 to 25, with emotional concerns that fall into the categories of mood and anxiety symptoms. The treatment takes a patient-centred approach in a youth-friendly setting where patients receive care from a multidisciplinary team.

"FEMAP helped me to understand that there wasn't something wrong with me and that I wasn't alone in the way that I felt. I learned to cope and deal with things in more constructive ways that made things so much easier. Before entering the program, I had trouble finishing school, no job prospects and couldn't hold down a relationship. Now, three years out of the program, I have a great job, am married and own a house, which are things I never thought would be possible," said research participant, Kirstie Leedham.

The study included 370 youth. Before beginning treatment, they were, on average, experiencing moderate depression, moderate anxiety and low satisfaction with their quality of health.

Of 370 youth eligible for treatment, 322 attended a clinical assessment. The research team found that those who disengaged early had less severe symptoms than those who stayed engaged.

Follow-up questionnaires were completed by 174 youth approximately six months into treatment. The research team discovered significant improvements in patient outcomes, including a reduction in mood and anxiety symptoms, improved functioning and a higher quality of health satisfaction.

"These results demonstrate the effectiveness of early intervention programs offering personalized treatment that adjusts to patient's needs and wishes. The data suggests our model is successful in helping patients manage their mood and anxiety disorders," said Dr Elizabeth Osuch, Clinician-Scientist.

"Our results suggest FEMAP provides access to mental health care in the most appropriate settings by preventing ED visits, demonstrating the health system potential of this novel treatment program," notes Dr Kelly Anderson, Associate Scientist.